# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001023024-25-000030
Filing Date
2025-03-31
Accepted
2025-03-31 16:35:44
Documents
29
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | anip-20250331.htm iXBRL | PRE 14A | 1624552
6 |  | anip-20250331_g1.jpg | GRAPHIC | 61789
7 |  | anip-20250331_g10.jpg | GRAPHIC | 84934
8 |  | anip-20250331_g11.jpg | GRAPHIC | 76730
9 |  | anip-20250331_g12.jpg | GRAPHIC | 524971
10 |  | anip-20250331_g13.jpg | GRAPHIC | 217751
11 |  | anip-20250331_g2.jpg | GRAPHIC | 37141
12 |  | anip-20250331_g3.jpg | GRAPHIC | 18458
13 |  | anip-20250331_g4.gif | GRAPHIC | 42522
14 |  | anip-20250331_g5.jpg | GRAPHIC | 94756
15 |  | anip-20250331_g6.jpg | GRAPHIC | 2547
16 |  | anip-20250331_g7.jpg | GRAPHIC | 2297
17 |  | anip-20250331_g8.jpg | GRAPHIC | 2598
18 |  | anip-20250331_g9.jpg | GRAPHIC | 2403
| Complete submission text file | 0001023024-25-000030.txt |  | 5530674

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | anip-20250331.xsd | EX-101.SCH | 2679
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | anip-20250331_def.xml | EX-101.DEF | 3058
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | anip-20250331_lab.xml | EX-101.LAB | 3512
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | anip-20250331_pre.xml | EX-101.PRE | 2110
31 | EXTRACTED XBRL INSTANCE DOCUMENT | anip-20250331_htm.xml | XML | 315798

Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-31812 | Film No.: 25793952
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)